Program for Neurodevelopmental Disorders
The Program for Neurodevelopmental Disorders is dedicated to studying the developmental neurobiological basis of pediatric onset neuropsychiatric disorders. We use neurochemical and molecular genetic research tools to develop new knowledge that may lead to improvement in clinical pharmacology. We began as a neurochemistry lab studying the relationship between hyperserotonemia and autistic disorder. We are now working with collaborators on molecular genetic and clinical pharmacological studies of autism, attention-deficit/hyperactivity disorder, and childhood onset obsessive-compulsive disorder.